Hengeler Mueller advises Novonesis in the context of the acquisition of dsm-firmenich's share of the Feed Enzyme Alliance

17 February 2025

Novonesis has entered into an agreement with dsm-firmenich to dissolve the Feed Enzyme Alliance and purchase its sales and distribution activities in exchange for a total cash consideration of EUR 1.5 billion. The transaction follows more than 25 years of successful collaboration between the parties. The acquisition aligns with Novonesis' strategic ambitions to expand its presence across the animal biosolutions value chain.

Hengeler Mueller has advised Novonesis regarding the Feed Enzyme Alliance Agreement in the context of the transaction.

Hengeler Mueller team for Novonesis

Daniel Engel (partner), Viola de Blecourt (senior associate, both Munich).

New Momentum for Reform of Media Concentration Control

2 May 2025

In Germany, initial steps have been taken to implement the European Media Freedom Act (EMFA). These could fundamentally change the regulatory framework for transactions in the media sector.Media

Inside Hengeler

Hengeler Mueller Panel @ Mergermarket M&A Forum 2025: Unlocking the Future - Tech M&A in the AI Age

24 April 2025

Many companies have already identified the use of artificial intelligence (AI) as a key component of their growth strategy - and are not only adapting structurally to the rapid changes in the economy,

EU Competition Law

Brussels à Jour: A Competitiveness Compass and Clean Industrial Deal for the EU

3 March 2025

When published in September, the Draghi report caused quite some stir in the Brussels bubble and across the continent, with people wondering what impact it will actually have on the bloc’s policies.

Recent Dispute Resolution Work

17 February 2025